seco erythromycin

CAS: 143416-84-6

Ref. 3D-AS16853

Produktinformation

• Name: seco erythromycin
• Synonyme: [2R-(2R*,3S*,4S*,5R*,6R*,8R*,10R*,11R*,12R*,13R*)]-3-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranosyl)oxy]-6,11,12,13-tetr ahydroxy-2,4,6,8,10,12-hexamethyl-9-oxo-5-[[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy]pentadecanoic
• Marke: Biosynth
• Beschreibung: Seco erythromycin is a derivative of the macrolide antibiotic erythromycin, which originates from the bacterium *Saccharopolyspora erythraea*. As a semi-synthetic compound, it retains the core lactone ring structure of erythromycin, but modifications in its chemical configuration confer distinct properties. Seco erythromycin operates by binding to the 50S subunit of the bacterial ribosome, inhibiting protein synthesis. This action effectively halts bacterial growth by preventing the translocation of peptides and thus impairs protein assembly.

Chemische Eigenschaften

• Molekulargewicht: 751.94 g/mol
• Formel: C₃₇H₆₉NO₁₄
• Reinheit: Min. 95%